FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial

Affiliation auteursAffiliation ok
TitreFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial
Type de publicationJournal Article
Year of Publication2017
AuteursBachet J-B., Lucidarme O., Levache C.B, Maillard E., Raoul J.L, Lecomte T., Desauw C., Brocard F., Pernot S., Breysacher G., Lagasse J-P., Di Fiore F., Etienne P.L, Dupuis O., Aleba A., Lepage C., Taieb J.
JournalANNALS OF ONCOLOGY
Volume28
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534